tiprankstipranks
Trending News
More News >
ARS Pharmaceuticals expects cash to fund operations for at least next 3 years
PremiumThe FlyARS Pharmaceuticals expects cash to fund operations for at least next 3 years
1M ago
ARS Pharmaceuticals reports FY24 EPS 8c, consensus (56c)
Premium
The Fly
ARS Pharmaceuticals reports FY24 EPS 8c, consensus (56c)
1M ago
SPRY Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
SPRY Upcoming Earnings Report: What to Expect?
1M ago
ARS Pharmaceuticals announces FDA approval for neffy 1 mg
PremiumThe FlyARS Pharmaceuticals announces FDA approval for neffy 1 mg
2M ago
ARS Pharmaceuticals Secures Major Formulary Wins, Strengthens Market Position for neffy
Premium
Ratings
ARS Pharmaceuticals Secures Major Formulary Wins, Strengthens Market Position for neffy
2M ago
Closing Bell Movers: Booking gains 3%, Akamai down 8% on earnings
Premium
The Fly
Closing Bell Movers: Booking gains 3%, Akamai down 8% on earnings
2M ago
ARS Pharmaceuticals launches neffyinSchools program
PremiumThe FlyARS Pharmaceuticals launches neffyinSchools program
3M ago
ARS Pharmaceuticals price target raised to $28 from $26 at Raymond James
Premium
The Fly
ARS Pharmaceuticals price target raised to $28 from $26 at Raymond James
3M ago
ARS Pharmaceuticals Highlights Success and Plans for 2025
Premium
Company Announcements
ARS Pharmaceuticals Highlights Success and Plans for 2025
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100